Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Entero Therapeutics ( (ENTO) ) has provided an update.
On October 17, 2025, the stockholders of GridAI Corp waived their right to appoint two directors to Entero Therapeutics, Inc.’s Board of Directors. This decision will remain in effect until the shareholders of Entero Therapeutics approve the appointment of such directors at a future meeting, impacting the company’s governance structure.
More about Entero Therapeutics
Average Trading Volume: 1,820,766
Technical Sentiment Signal: Hold
Current Market Cap: $6.45M
For an in-depth examination of ENTO stock, go to TipRanks’ Overview page.